NCT00330174View on ClinicalTrials.gov

Acamprosate in Alcoholics With Comorbid Anxiety or Depression

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
Alcohol DependenceMajor DepressionSocial Anxiety DisorderGeneralized Anxiety Disorder
Interventions
DRUG

Acamprosate

2 333mg tablets three times daily

Trial Locations (3)

10025

Columbia University College of Physicians & Surgeons, New York

29671

Behavioral Health Services of Pickens County, Pickens

02478

McLean Hospital, Belmont

All Listed Sponsors
collaborator

Mclean Hospital

OTHER

collaborator

Columbia University

OTHER

lead

Medical University of South Carolina

OTHER

NCT00330174 - Acamprosate in Alcoholics With Comorbid Anxiety or Depression | Biotech Hunter | Biotech Hunter